Meditation duration

There is no evidence-based upper limit for ordinary daily practice. In a representative United States survey, ordinary session duration and weekly frequency were not significant adjusted predictors of adverse effects, while meditation retreat participation was associated with more unusual experiences and functional impairment. Retreat intensity is difficult to interpret because it bundles long practice with silence, sleep changes, dietary changes, social context and participant self-selection. For everyday practice at the lengths discussed here, no study has found ordinary session length to predict adverse effects, though adverse-event measurement in this literature is inconsistent.

Most do not, and the honest figures are lower than intentions suggest. In a 2026 study of 655 Medito users with objective usage data, 18.86% were still using the app after day 14, and median total use across the first 30 days was 16.11 minutes. Users intended to practise an average of 418 minutes in that first month and actually practised 70. Across 70 randomised trials of mindfulness apps, pooled attrition was 24.7%, rising to a projected 38.7% in larger trials.

The randomised evidence does not show that it does, within the range that has been tested. Six trials have assigned people to different session lengths, and none found a reliable advantage for longer sessions on mental health, wellbeing, affect or mindfulness outcomes. This is not proof that length is irrelevant, because most of these were superiority trials rather than equivalence trials, and several were small. Observational studies of self-selected practice sometimes do find associations with longer daily practice, but those cannot separate the effect of the dose from the characteristics of people who choose it.

Frequency has better supporting evidence than session length, though most of it is observational. In an analysis of 289,630 logged sessions, people practising four to seven days a week were 2.33 times as likely to reach their 150th session as those practising one day a week, and session length showed no association with mood change. Note that this predicts persistence rather than symptom improvement. One randomised trial that held the daily total constant found no advantage for splitting practice into two shorter sessions rather than one longer one.

Ten minutes is a reasonable and widely used session length, but it is a product convention rather than a scientifically established dose. It became a consumer norm largely through early meditation apps and a 2012 TED talk titled All it takes is 10 mindful minutes. No published experiment, patent or founder statement was found showing that 10 minutes was selected because it maximised clinical effect. In the trials that have compared doses directly, no study found the 20 or 30-minute conditions to be reliably better than 10.

Morning practice is associated with sticking with meditation for longer, though not with each session being more effective. In the analysis of 289,630 sessions, morning practitioners were 2.1 times as likely to reach their 150th session compared with evening practitioners. A smaller daytime advantage was also reported, though that estimate did not survive the study’s correction for multiple comparisons. This is observational data, so it cannot establish that the time of day causes the persistence. A plausible alternative explanation is that mornings are simply more protected from interruption for many people.

No minimum has been established. Two figures circulate widely, 13 minutes and 15 minutes, and both misread their source studies: the first compared meditation against a control rather than against shorter meditation, and the second let 17 participants choose their own duration, with dose unrelated to outcome. Across the six trials that deliberately varied session length, none identified a threshold below which practice stopped working. Among the contemporary teachers reviewed by Bowles and colleagues, suggestions clustered around 15 to 30 minutes with 5 to 10 minutes used to establish the habit, but those come from pedagogy and tradition rather than dose-response experiments. A practical starting point is a length you are confident you can repeat the next day.

Because that was the length chosen when the programme was designed, not because a trial identified it as optimal. In interview material reproduced in a 2026 review, Jon Kabat-Zinn is quoted as saying that 45 minutes seemed long enough to settle into stillness and sustained attention, and describing the choice as a good intuition. Those words have not been verified against a primary text by Kabat-Zinn himself, so they are reported here at one remove. MBSR has strong clinical evidence as a complete package, but that evidence supports the programme, not the necessity of each individual minute. Participants in MBSR and MBCT trials complete around 64% of assigned home practice on average, so the dose that produced those results was in practice shorter than the prescription.